VXRT (vaxart.com) Dhuwit awis perusahaan

The uniqueness of tablet vaccines provides Vaxart, Inc. (VXRT) with technological leadership and high margins. The size of the cash position demonstrates current liquidity, where 0.00 serves as the final level marker. The project simplifies preventative logistics, reducing biotechnological risks. Capitalization growth depends on BARDA funding, Phase II test results, and the launch of global studies for influenza and norovirus drugs.
Vaxart, Inc. (VXRT) - rincian metrik lan laporan keuangan

Vaxart, Inc. (VXRT) is conducting large-scale development of innovative oral medications. By analyzing cash flow dynamics, an investor can see the actual balance of liquid assets on the accounts. This metric measures the company's ability to fund operating activities without resorting to external loans. A stable cash reserve amid low geopolitical risks guarantees the uninterrupted development of technologies, confirming the high financial stability of the business.